""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent_orig"	"response_agent"	"proterm"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"publication_reference_url"	"subObsID"	"uniqObsID"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"
"role"	""	""	""	"tissue"	"background"	"cell_biomarker"	"background"	"background"	"measured"	"background"	"observed"	"observed"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"reference"	"background"	"background"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (original)"	"response agent (cell subset)"	"cell type details"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"target pathogen"	"vaccine year"	"exposure material"	""	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"publication url"	"ID of observation within its submission"	"Uniq ID of observation within submission type"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"whole blood"	"T cells IFNg producing VZV-specific CD4+"	"CD4-positive, alpha-beta T cell"	"IFNg producing, VZV-specific"	"cell type frequency"	"up"	""	""	""	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	""	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"1"	"144"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"T cells CD4+"	"CD4-positive, alpha-beta T cell"	""	"cell type frequency"	"up"	""	"3"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"2"	"145"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"T cells CD4+"	"CD4-positive, alpha-beta T cell"	""	"cell type frequency"	"up"	""	"7"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"3"	"146"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"T cells CD8+"	"CD8-positive, alpha-beta T cell"	""	"cell type frequency"	"up"	""	"3"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"4"	"147"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"T cells CD8+"	"CD8-positive, alpha-beta T cell"	""	"cell type frequency"	"up"	""	"7"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"5"	"148"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"T cells CD8+ Ki67+"	"CD8-positive, alpha-beta T cell"	"Ki67+"	"cell type frequency"	"up"	""	"3"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"6"	"149"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"T cells CD8+ Ki67+"	"CD8-positive, alpha-beta T cell"	"Ki67+"	"cell type frequency"	"up"	""	"7"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"7"	"150"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"Tregs Foxp3+"	"regulatory T cell"	"Foxp3+"	"cell type frequency"	"down"	""	"3"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"8"	"151"
""	"20191009-hipciof_ctf_30247603"	"2019.10.09"	"hipciof_ctf_32"	"skin of body"	"Tregs Foxp3+"	"regulatory T cell"	"Foxp3+"	"cell type frequency"	"down"	""	"7"	"days"	"Human alphaherpesvirus 3"	""	"Zostavax"	"VO_0000124"	"Varicella zoster virus (VZV) antigen challenge"	"After vaccine vs before vaccine"	"Time of vaccination (first dose)"	"Adults (70-93)"	"30247603"	"2018"	"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151076/"	"9"	"152"
